Myriad Genetics, Inc. Company Profile

01:08 EDT 25th March 2018 | BioPortfolio

Myriad Genetics, Inc. is a biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products. Myriad's news and other information are available on the Company's Web site at BRACAnalysis(R) is a registered trademark of Myriad Genetics, Inc. in the U.S. and other countries.

News Articles [444 Associated News Articles listed on BioPortfolio]

Myriad Genetics Inc. Q2 Income Advances

WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) released earnings for its second quarter that gained ground from last year.The company said its bottom line came in at $22.3 million, or $0.31 pe...

Walter Phd Gilbert Sells 7,500 Shares of Myriad Genetics, Inc. (MYGN) Stock

Myriad Genetics, Inc. Director Walter Phd Gilbert sold 7,500 shares of Myriad Genetics stock in a transaction dated Thursday, December 14th. The shares were sold at an average price of $33.19, for a t...

Myriad Genetics Raises FY18 Financial Guidance

WASHINGTON (dpa-AFX) - Myriad Genetics, Inc. (MYGN) announced, for fiscal 2018, the company expects adjusted earnings per share of $1.11-$1.16; and revenue in the range of $760-$770 million. For t...

Myriad Genetics, Inc. (MYGN) Releases Q2 Earnings Guidance

Myriad Genetics, Inc. updated its second quarter earnings guidance on Tuesday. The company provided earnings per share guidance of $0.22-0.24 for the period, compared to the Thomson Reuters consensus ...

Active-Investors: Wired News - Myriad Genetics Announces Expanded Research Collaboration with AstraZeneca

Stock Monitor: AstraZeneca Post Earnings Reporting LONDON, UK / ACCESSWIRE / January 05, 2018 / has just released a free research report on Myriad Genetics, Inc. (NASDAQ: MYGN)...

AZ deepens ties with Myriad on Lynparza companion test

AstraZeneca has expanded its agreement with US group Myriad Genetics to identify women with advanced ovarian cancer most likely to benefit from its medicines.

Myriad Genetics shows strong commitment, support in the fight against colorectal cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment to hereditary cancer risk assessment and genetic testing during Nat...

Myriad’s myRisk Hereditary Cancer test finds inherited gene mutations in more than 12% of prostate cancer patients

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that results from a large 1,162 patient study of the Myriad myRisk Hereditary Cancer test will be fe...

Drugs and Medications [0 Results]


PubMed Articles [605 Associated PubMed Articles listed on BioPortfolio]

Skull Base Neuroendoscopic Training Model Using a Fibrous Injectable Tumor Polymer and the Nico Myriad.

The Myriad is an innovative, high precision tool for tumor resection, designed to work within narrow endoscopic corridors. Due to its application in technically demanding situations, the learning curv...

Living with a rare disorder: a systematic review of the qualitative literature.

Individuals with rare diseases may face challenges that are different from those experienced in more common medical conditions. A wide range of different rare conditions has resulted in a myriad of st...

Introduction to behavioral phenotypes in medical genetics.

Medical genetics and genomic medicine in the United States. Part 2: Reproductive genetics, newborn screening, genetic counseling, training, and registries.

Review of genetics in the United States with emphasis on the prenatal, metabolic, genetic counseling, and training aspects of the field.

Genetics and Psychiatry: Myth or Reality?

Greek mythology and philosophical speculations were the first human productions on madness and psychiatry. Likewise, the origins of genetics sink their roots in a very remote and difficult time. This ...

Clinical Trials [322 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Cultural Congruence in International Genetics Research

This study will explore how cultural differences influence genetics research in developing countries. Human genetics research is becoming more common in developing countries. However, when...

Companies [61 Associated Companies listed on BioPortfolio]

Myriad Genetics, Inc.

Myriad Genetics, Inc. is a biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products. Myriad's news and other information are available on t...

Myriad House

PR Week ranks Myriad as a UK top 150 PR agency and as number one in Cambridgeshire and across the East of England region. One of the country’s leading healthcare agencies, and among the largest...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

More Information about "Myriad Genetics, Inc." on BioPortfolio

We have published hundreds of Myriad Genetics, Inc. news stories on BioPortfolio along with dozens of Myriad Genetics, Inc. Clinical Trials and PubMed Articles about Myriad Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Myriad Genetics, Inc. Companies in our database. You can also find out about relevant Myriad Genetics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record